NFE2L2 and lung carcinoma: As reported by Bingjie Liu et al., NRF2 could also reversely regulate miRNA by increasing the transcription of miR-196a to decrease the expression of glycolipid transfer protein (GLTP), which caused resistance in lung cancer cells to gefitinib and other tyrosine kinase inhibitors (TKIs) [85].